Search Results 291-300 of 6252 for younkin
This phase II trial studies how well pembrolizumab, lenalidomide, and dexamethasone work in treating patients with newly diagnosed multiple myeloma that are ...
He is a former broadcast journalist and news director. Joel has been with Mayo Clinic since 2001, first as a contract employee and then officially joining the ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
... Younkin SG, Wszolek ZK, Low PA, Singer W, Bu G, Dickson DW, Ross OA. Association study between multiple system atrophy and TREM2 p.R47H. Neurol Genet. 2018 ...
This study is designed to explore the experiences of individuals growing up with a genetic diagnosis of SCAs and their families. Participation eligibility.
This research is being done to observe the safety, tolerability, side effects, and effectiveness of the ketogenic diet in people with continuous seizures ( ...
The objectives of this study are to create a proteomic profile (Host Response) using plasma from patients before and after anti-cancer therapy, and to associate ...
About this study. This screening and multi-sub-study Phase 1b/2 trial will establish a method for genomic screening followed by assigning and accruing ...
The purpose of this study is to assess Electrical Impedance Myography (EIM) as an outcome measure in patients with Idiiopathic Inflammatory Myopathies (IIM) or ...
About this study. Muscle proteins accumulate damage during aging and leads to the loss of muscle mass and function in older people.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.